Background: Shared decision making (SDM) is a widely recommended yet unproven strategy for increasing colorectal cancer (CRC) screening uptake. Previous trials of decision aids to increase SDM and CRC screening uptake have yielded mixed results.
Introduction
C olorectal cancer remains a leading cause of cancer-related morbidity and mortality, despite recent declines in both incidence and mortality.
1,2 A compelling body of evidence has accumulated to suggest that screening is the most effective and rational strategy for further reducing the public health burden of this deadly yet potentially preventable disease. Consequently, screening is now endorsed by most, if not all, authoritative groups, including the U.S. Preventive Services Task Force, American Cancer Society, and U.S. Multi-society Task Force on Colorectal Cancer. 3, 4 These endorsements, combined with more-widespread coverage by medical insurers and heightened public awareness efforts, have contributed to a steady increase in screening prevalence in recent years. Nevertheless, more than one third of age-eligible Americans have never been screened. 5 Eliciting patient preference within the context of shared decision making (SDM) has been advocated as a potentially effective strategy for increasing patient acceptance and adherence to CRC screening recommendations. 3, 4 Engaging patients to participate in the decisionmaking process when confronted with preference-sensitive choices related to CRC screening is also fundamental to the concept of patient-centered care. 6 -8 CRC screening is ideally suited for this approach given the availability of multiple options with distinct advantages and disadvantages, the lack of consensus regarding an optimal costeffective strategy, and limited effectiveness of the moretraditional paternalistic approach in which providers assume full responsibility for the decision-making process. Further support is derived from studies fınding that both patients and providers hold distinct preferences for the various screening options, 9 -14 that providers often misperceive patient preferences, 10 and that many patients endorse an SDM approach for CRC screening. 15, 16 Despite a compelling rationale, SDM has been diffıcult to implement in routine clinical practice in part because of lack of time, resources, clinician expertise, and suitability for certain patients or clinical situations. 17, 18 The use of patient-oriented decision aids has been proposed as a potentially effective strategy for circumventing several of these barriers. 8, 19 Decision aids help patients make informed, value-concordant choices about a particular course of action based on an understanding of potential benefıts, risks, probabilities, and scientifıc uncertainty. 20 Studies to date have shown that decision aids for CRC screening enable users to identify a preferred screening option, 11, 16, [21] [22] [23] [24] [25] reduce decisional conflict, 22, 24 and increase interest in screening. 21, 23, 25, 26 The authors recently have shown that decision aids also can facilitate SDM by increasing patient knowledge, increasing satisfaction with the decision-making process, enhancing screening intentions, and improving the quality and effıciency of the patient-provider encounter. 16, 27 The extent to which decision aids increase CRC screening uptake, however, is less well defıned. [21] [22] [23] [24] [25] 28 Hence, the primary objective of the present study was to test the hypothesis that decision-aid users were more likely to complete a CRC screening test than non-users. Unlike previous such studies, effectiveness was evaluated within the context of a shared rather than informed decision-making framework. 29 Based on evidence suggesting that individualized risk communication also might increase uptake of screening tests, 30 a secondary objective was to test the hypothesis that a modifıed version of the decision aid that incorporated a validated personalized risk assessment tool for CRC would be more effective than the decision aid alone for increasing test completion.
Methods Study Population and Recruitment Process
The study sample was made up of average-risk primary care patients cared for at Boston Medical Center or the South Boston Community Health Center. Patients were deemed eligible if they were aged 50 -75 years and due for CRC screening. 3, 4 Patients meeting any of the following criteria were excluded: (1) prior CRC screening by any method other than fecal occult blood testing (FOBT); (2) high-risk condition (personal history of colorectal cancer or polyps, family history of colorectal cancer or polyps involving one or more fırst-degree relatives, or chronic inflammatory bowel disease); (3) lack of fluency in written and spoken English; or (4) comorbidities that preclude CRC screening by any recommended method, as determined by primary care provider (PCP). The decision to exclude patients with prior screening other than FOBT was based on concerns that such patients may be more likely to adhere to repeat testing than previously unscreened patients. Conversely, patients with prior FOBT were included because of institutional data suggesting that they were less likely to adhere to repeat testing and thus potentially more likely to consider alternative screening options after reviewing the decision aid.
Three different recruitment strategies were used during the course of the study. The vast majority of patients (nϭ796) were recruited using an "opt-out" approach in which patients due for screening were identifıed from monthly audits of the electronic medical record 2-4 weeks before a scheduled offıce visit and contacted directly by telephone by a research assistant if deemed appropriate by the patient's PCP. Those expressing interest were provided with a brief overview of the study, evaluated for eligibility, and invited to participate. Two other PCP-mediated strategies, including an "opt-in" electronic flagging approach (nϭ12) and "opt-in" letter approach (nϭ17), were used initially but were discontinued after 6 months because of low enrollment. Details of each of these approaches and their relative cost effectiveness have been published previously. 31 
Setting
The study was conducted at two urban ambulatory care sites. The fırst, Boston Medical Center (BMC), is an urban, nonprofıt academic medical center affıliated with the Boston University School of Medicine, which serves a mostly low-income, racially/ethnically diverse patient population. The second, the South Boston Community Health Center (SBCHC), is a community health center affıli-ated with BMC, which serves a mostly non-Hispanic white, lowincome patient population. Both sites use the same electronic medical record system (Centricity™). The study protocols were approved for both sites by the Boston University Medical Campus IRB.
Provider Characteristics and Training
Sixty-one primary care providers, including 47 board-certifıed general internists, 11 board-certifıed family physicians, and three nurse practitioners, practicing at both BMC and the SBCHC participated in the study. Pre-trial training seminars and annual refreshers were conducted at both sites to educate providers about the current status of CRC screening highlighting the recommendation for SDM, provide an overview of the study design, and elicit support. The meetings also provided a venue for informing participating providers about the status of recruitment and addressing any logistic problems that they experienced related to the study. All providers attended at least one of the meetings. By design, no formal training in SDM was undertaken.
Study Design
An RCT was conducted between April 2005 and December 2010 to evaluate the impact of the decision aid on SDM and screening behavior. Eligible patients were instructed to arrive 1 hour before a prearranged chronic care visit with their primary care provider. Each received a pre-visit reminder call to ensure that the patient had no acute medical illnesses that would preclude the CRC screening discussion.
After informed consent was obtained, patients were administered a 10-minute, paper-based pretest that assessed knowledge, beliefs, attitudes and behaviors related to CRC screening, as well as level of desire for participating in decision making related to CRC screening. The pretest was administered using a structured interviewer format by one of fıve trained research assistants in a private offıce located in one of the ambulatory care clinics of the participating sites. After completing the pretest, patients were randomized to one of two intervention arms (decision aid alone or decision aid plus YourDiseaseRisk (YDR; personalized risk assessment tool with feedback) or usual care with stratifıcation by provider. Patients randomized to the usual care arm reviewed a modifıed online version of "9 Ways to Stay Healthy and Prevent Disease," which discussed generic lifestyle changes other than screening for minimizing risk of preventable diseases.
Immediately after completing the interactive computer session, patients met with their providers to discuss screening and identify a preferred screening strategy. Providers received written notifıca-tion hand-delivered by all the patients acknowledging that they were participating in the "CRC decision aid study" at the time of the visit to ensure that screening was discussed; no information was provided regarding preferences or factors influencing choice for patients in the intervention arms. Before leaving the clinic, patients completed a 10-minute, paper-based post-test, again using a structured interviewer format, which assessed whether CRC screening was discussed, whether a screening strategy was chosen, patient satisfaction with the decision-making process, and screening intentions; the post-test also reassessed knowledge, beliefs, and attitudes related to CRC screening.
Decision Aid
Details of the decision-aid's theoretic framework, development, content and usability testing have been published previously. 16 In brief, the DVD-formatted tool employed an audiovisual and touch-screen design to simplify use for individuals with limited literacy and/or computer skills. The tool consists of a series of modules, in which professional actors playing the role of a black, Hispanic female moderator and a white, non-Hispanic male physician convey relevant information via on-screen video, animation and/or graphics.
The modules include:
1. an introductory segment that briefly discusses the importance of screening, purpose of the tool, and instructions in its use; 2. a brief overview of the epidemiology of CRC, natural history, benefıts of screening, availability of multiple screening options, and the lack of consensus regarding a best screening method; 3. brief descriptions of fıve screening methods (FOBT, flexible sigmoidoscopy, the combination of FOBT plus flexible sigmoidoscopy, DCBE, and colonoscopy) endorsed at the time the study was initiated 32-34 ; 4. audio and visual comparisons of each method with respect to individual test features; 5. a summary of the different test features for each method with optional links to additional information about the preparation or test itself, as well as vignettes from patients describing their experience with a particular test; 6. a decision-making module where users are asked to identify a screening preference (including no screening) and rank-order test features influencing their selection; 7. a concluding segment in which the narrator encourages users to discuss screening and their preferences with their doctor.
A modifıed version of the decision aid also was created that incorporated the web-based YDR CRC risk assessment tool (www. yourdiseaserisk.wustl.edu), in order to assess whether personalized 10-year CRC risk feedback influenced decision making. The risk estimate was conveyed using qualitative framing ("very much below average risk" to "very much above average risk") with accompanying suggestions for behavior modifıcations that might reduce risk, including a strong recommendation for screening, regardless of risk. The decision aid took between 20 and 30 minutes to complete, depending on which of the optional segments users chose to review.
Measures
The primary outcome measure was completion of a CRC screening test within 12 months of the study visit. Because of long waiting times (Ն3 months) and high cancellation rates (Ͼ20%) at the start of the study, the 12-month time frame was selected a priori to allow suffıcient time for patients who needed to cancel an endoscopic screening procedure to complete the rescheduled examination. Secondary outcomes included test uptake at 6 months and test ordering at 1, 3, 6, and 12 months post-study visit.
All outcomes were tracked using electronic clinical data reporting systems, which captured results for all endoscopic procedures, imaging studies, and FOBT completed at the participating sites, and evaluated using an intention-to-treat analysis. Other outcomes of interest included the identifıcation of predictors of test completion and mediators of the intervention effect. Mediators were defıned as measures that (1) signifıcantly changed as a consequence of the intervention (e.g., screening intentions 16 ); (2) had a signifıcant independent effect on the primary outcome of interest (i.e., test completion); and (3) diminished the intervention's effect on the primary outcome in the adjusted model. 35 
Sample Size and Power Considerations
Sample size and power considerations focused on a two-group comparison of the decision aid alone versus control study arms for the primary outcome of CRC screening test completion at 12 months. Based on crude estimates of baseline test uptake, it was determined that a target sample of 275 subjects per arm provided greater than 80% power of detecting a 54% versus 40% difference in the percentage of patients completing a CRC screening test within 12 months of the study visit.
Statistical Analyses
Data analysis was completed in 2011. As a check on randomization, the three study groups were fırst compared on demographic characteristics, prior FOBT screening, risk perception, and desired role in decision making through the chi-square test of independence. Chi-square tests also were used to compare the percentage of patients in the decision aid-alone group to those in the control group or decision aid plus YDR group who either had a test ordered or completed at each of the designated time points. Logistic regression was used to identify patient-level determinants of test completion and mediators of the intervention effect. Details regarding measurement of patient knowledge, satisfaction with the decisionmaking process, and screening intentions were published previously. 16 Variables exhibiting a signifıcant association with test completion in univariate analyses at the two-tailed pϽ0.05 level were included as covariates in the multivariate analyses. Sobel tests were performed to assess signifıcance for the mediation analyses. 36 All other analyses were conducted using SAS 9.2.
Results

Patient Characteristics
Of the 13,518 patients identifıed as potentially eligible for screening because of age, 7619 (56%) were deemed ineligible (mostly due to prior screening [nϭ6073]) and 5074 (38%) were excluded (Figure 1 ). Reasons for exclusion included inability to contact (nϭ4321); disinterest (nϭ290); scheduling conflict (nϭ305); and failure to keep appointment (nϭ158). The remaining 825 patients (52% of eligible subjects contacted) were enrolled and randomized to decision aid-alone (nϭ269); decision aid plus YDR (nϭ280); or control (nϭ 76) arms.
The three study arms were well-balanced with respect to all baseline characteristics, including patient age, gender, ethnicity, race, marital status, education, insurance coverage, prior FOBT, and decision-making preference (Table 1) .
Overall, the study group was mostly aged Ͻ65 years (84%); female (59%); non-Hispanic (95%); and black (62%), with at least a high-school degree (78%). Only 36% were married or living with a partner. Although most had some form of healthcare insurance (98%), nearly two thirds were covered by Medicare, Medicaid, or Massachusetts' "Free Care" (now "Commonwealth Care") program. Most (87%) had no prior FOBT. The majority preferred a patient-dominant (27%) or shared decision-making approach (53%) for selecting a preferred CRC screening option.
Intervention Effects on Test Ordering and Completion
Patients in the decision aid-alone group were more likely to have a test ordered than the control group at the 1-month (69.1% vs 60.5%, pϽ0.035); 3-month (71.8% vs 62.3%, pϭ0.019); 6-month (77.0% vs 65.2%, pϭ0.002); and 12-month (80.7% vs 71.4%, pϭ0.011) time points ( Table 2 ). The decision aid-alone group also was more likely to have a test ordered than the decision aid plus YDR group at each of these points, but here the differences were only signifıcant at 1 month (69.1% vs 60.4%, pϽ0.031); 6 months (77.0% vs 67.1%, pϽ0.010); and 12 months (80.7% vs 73.6%, pϭ0.048). The pattern of test ordering was similar for the three groups; regardless of patient preferences, colonoscopy was the most commonly ordered test (range, 79%-81%) followed by FOBT (13%-19%); flexible sigmoidoscopy (Ͻ2%); and barium enema (Ͻ2%). 
Mediators of Intervention Effects
Patients in the decision aid-alone group were more likely than controls to discuss screening at the study visit (93% vs 86%, pϭ0.008) even though all patients were given written prompts to hand to their providers acknowledging their participation in the study. As previously reported, 16 other measures of SDM including post-test knowledge, satisfaction with the decision-making process, and screening intention scores also were higher for the two intervention groups than they were for controls (Appendix B, available online at www.ajpmonline.org). As shown in Table 5 , whether or not screening was discussed at the study visit (AORϭ3.24, 95% CIϭ1.73, 6.05) and screening intentions (AORϭ1.69, 95% CIϭ1.25, 2.28) were independent post-intervention determinants of test completion after adjustment for study group, race, and decision-making preference. Controlling for both determinants diminished the positive association for the decision aid-alone group (AORϭ1.30, 95% CIϭ0.90, 1.87), suggesting a mediation effect, which was confırmed using Sobel tests for signifıcance (screening discussion, pϭ0.026; intentions, pϭ0.038). Post-intervention knowledge, satisfaction with the decision-making process, patient preferences, and concordance between patient preference and test ordered showed no association with test completion.
Discussion
The current study provides new evidence that decision aid-assisted SDM is an effective strategy for increasing CRC screening. Test completion uptake was ϳ8% higher among decision-aid users than controls at both 6 and 12 months, suggesting a very modest but sustained impact on screening uptake. Unlike previous such studies, the present study also explored the role of individual elements of SDM on screening behavior and found that the positive impact was mediated through activation of the screening discussion and heightened screening intentions rather than increased knowledge, satisfaction with the decision-making process, or concordance between patient preference and test ordered. Because providers received written notifıcation of participation in the study from all patients, the authors speculate that enhanced activation of the screening discussion in the decision-aid group was the result of patient empowerment rather than differential provider behavior in response to the cue.
Another important fınding was that use of a decision aid that incorporates a personalized risk assessment tool fails to increase test completion compared to a decision aid lacking the tool. Unlike for conditions where the benefıts of screening are less certain, the primary goal of SDM for CRC screening is to enable patients to identify a preferred screening option rather than to decide whether or not to undergo screening. 4, 7, 8 Consequently, personalized risk feedback might have a detrimental effect without appropriate framing. Individuals deemed to be at higher risk may be fearful of the potential fındings, whereas those at lower risk may feel that screening is unnecessary, especially if they overestimated their lifetime risk of cancer before receiving the feedback. 37 Results of the current study contribute to a growing body of evidence suggesting that patient-level interventions alone have a relatively modest impact on CRC screening. The use of tailored educational approaches, 38 -41 patient reminders, 42, 43 activation strategies, 44 and as previously noted, decisions aids, [21] [22] [23] [24] [25] 28 have demonstrated either no effect or slight increases in screening uptake that rarely exceed 20% compared to control groups. With the steady rise in screening prevalence nationally, 5 this limited effectiveness partly could reflect the challenges of trying to reach a more recalcitrant patient population. Regardless, this experience highlights the need for additional multilevel interventions that address not only patient-level but also provider-and systemlevel barriers to participation.
Several clinical implications of the current study are notable. The fındings and feedback from providers attest to the feasibility and validity of using decision aids as a point-of-contact intervention in clinical practice. 27 The observation that patients who preferred a patient-dominant decision-making style were more likely to complete screening provides new evidence supporting the importance of assessing a patient's desire to participate in the decision-making process prior to engaging in SDM. Conversely, the lack of association between concordance and test completion suggests that complying with patient preferences may be less important in select patients than the provider's ability to effectively communicate his/her reasoning for recommending a preferred strategy. However, failure to comply with patient preferences negatively influenced test ordering and thus compromised the overall impact of SDM on screening uptake. The observation that blacks were more likely than whites to complete a screening test in a safety-net healthcare system corroborates previously published data suggesting that barriers to access and socioeconomic inequalities rather than cognitive factors may be responsible largely for racial disparities in screening rates. 45 
Limitations and Strengths
Limitations to the present study include the fact that lack of provider blinding may have influenced negatively the magnitude of the interventions' effect on outcomes of interest. Second, no attempt was made to assess the quality of the patient-provider discussion. Even though satisfaction with the decision-making process was universally high (albeit higher in the intervention groups), recent data suggest that most patient-provider discussions related to CRC screening often fail to incorporate key elements of informed decision making. 15, 46 Third, the current study did not explore reasons for the large discrepancy between test ordering and test completion for each of the study arms. Although outcome assessment does not preclude the remote possibility that some patients may have completed tests elsewhere, the authors speculate that well-described patient-and system-level barriers to participation are largely responsible. 47 Lastly, no attempt was made to assess the cost effectiveness of the intervention from the perspective of the provider or healthcare center.
Despite these limitations, this study has several notable strengths. First, it is the largest study to date to demonstrate that the use of decision aids to promote SDM has a positive impact on screening behavior. Second, the use of an RCT study design, large sample size, and diverse study population enhances both the internal and external validity of its fındings. Third, the randomization scheme after stratifıcation by provider, and inclusion of mostly unscreened patients, minimizes potential confounding.
Conclusion
The present study fınds that decision aid-assisted SDM has a modest impact on CRC screening uptake, even when provider and patient preferences differ. The fındings also suggest that decision aids not only enable patients to identify a value-concordant screening preference but also empower them to initiate the screening discussion and heighten screening intentions. Conversely, incorporating personalized risk feedback may have negative consequences on screening behavior in the absence of appropriate messaging that motivates patients to undergo screening regardless of risk. Despite its importance, however, SDM alone is unlikely to have a profound impact on CRC screening uptake unless strategies are in place to address patient-and system-level barriers to participation.
